Early Palliative Care Improves Survival in Advanced Cancer

Share this content:
Early Palliative Care Improves Survival in Advanced Cancer
Early Palliative Care Improves Survival in Advanced Cancer

FRIDAY, March 27, 2015 (HealthDay News) -- Early initiation of palliative care (PC) interventions improves survival and caregiver burden in advanced cancer, according to two studies published online March 23 in the Journal of Clinical Oncology.

Marie A. Bakitas, D.N.Sc., C.R.N.P., from the University of Alabama at Birmingham, and colleagues conducted a randomized trial involving 207 patients with advanced cancer. Participants were randomized to receive an in-person PC consultation, structured PC telehealth nurse coaching sessions, and monthly follow-up, early after enrollment or three months later. The researchers found that patient-reported outcomes did not differ significantly after enrollment or before death. One-year survival rates were 63 and 48 percent in the early and delayed groups, respectively (P = 0.038).

J. Nicholas Dionne-Odom, Ph.D., also from the University of Alabama, and colleagues examined the effect of early versus delayed initiation of a PC intervention for 122 caregivers of 207 patients with advanced cancer. Caregivers were randomized to receive thee weekly telephone coaching sessions, monthly follow-up, and a bereavement call early after enrollment or after three months. The researchers found that between-group differences in depression scores for enrollment to three months favored the early group. No differences were seen in quality of life (QOL) or burden. For depression and stress burden, but not for QOL, in decedents' caregivers there were between-group differences favoring the early group.

"If palliative care makes a difference for patients and family caregivers, and if earlier is better, why wait?" writes the author of an accompanying editorial.

One author from each study disclosed ties to Johnson & Johnson.

Abstract - Bakitas
Full Text (subscription or payment may be required)
Abstract - Dionne-Odom
Full Text (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »